BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $111 at Stifel
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $59.46 -1.33%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $111.00 (from $114.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Karman Holdings Inc (KRMN) PT Lowered to $70 at RBC Capital
- AppFolio (APPF) PT Raised to $240 at DA Davidson on Strong Growth Profile
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
